C0041984||Uridine
C0282090||laxative
C0023992||loperamide
C0009806||constipation
C2699239||SD rats
C1327386||regulation
C0034826||mAChRs
C0037080||signaling pathway
C0026682||mucin
C0036536||secretion
C0041984||Uridine
C0041984||Uridine
C0700287||reported
C0035668||RNA
C3714634||biological process
C0598958||neuroprotection
C0017952||glycolysis
C0009806||constipation
C2603343||study
C0282090||laxative
C0041984||Uridine
C0009806||constipation
C0009806||constipation
C0227386||transverse colons
C2699239||SD rats
C0023992||loperamide
C0023992||loperamide
C0009806||constipation
C0087111||treatment
C0041984||Uridine
C0043047||water
C0015733||stools
C0023992||loperamide
C0041984||Uridine
C0332154||treated
C0023992||loperamide
C0042444||Vehicle
C0332154||treated
C0013470||food intake
C0013123||water consumption
C0026724||mucosa layer
C0026845||muscle
C1180160||flat luminal surface
C0506994||goblet cells
C0227276||paneth cells
C0230704||lipid droplets
C0023992||loperamide
C0041984||Uridine
C0332154||treated
C1171362||expression
C0384752||muscarinic acetylcholine receptors M2
C0289799||M3
C0384752||mAChR M2
C0289799||M3
C1158770||transcriptional
C3537096||translational
C0023992||loperamide
C0041984||Uridine
C0332154||treated
C0005516||markers
C0887847||Gα
C0522506||downstream
C0037080||signaling pathway
C0041984||Uridine
C0087111||treatment
C0026682||mucin
C0036536||secretion
C1171362||expression
C0599635||membrane water channel
C1743716||aquaporine 8
C1743716||AQP8
C0023992||loperamide
C0041984||Uridine
C0332154||treated
C0023992||loperamide
C0042444||Vehicle
C0332154||treated
C0041984||Uridine
C1267092||primary smooth muscle
C0086893||rat
C0814997||intestine cells
C1135918||pRISMC
C0887847||Gα
C1171362||expression
C2603343||study
C0041984||Uridine
C0009806||constipation
C0023992||loperamide
C0087111||treatment
C0599779||animal models